Rivus Pharmaceuticals
rivuspharma.comRivus pharmaceuticals, inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called controlled metabolic accelerators (cmas). Rivus’ cmas are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (shtg), non-alcoholic steatohepatitis (nash), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (hfpef).
Something looks off?Open jobs at Rivus Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.